반응식
[Cl:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[N:7]([CH2:11][C:12]([OH:14])=[O:13])[C:6]([CH3:15])=[C:5]2[C:16]1[CH:17]=[CH:18][CH:19]=[C:20]2[C:25]=1N=CC=C2.[NH:26]1C2C(=CC(B(O)O)=CC=2)[CH:28]=[CH:27]1.C(=O)([O-])[O-].[K+].[K+].[C:44]1(C)C=CC=C[C:45]=1P(C1C=CC=CC=1C)C1C=CC=CC=1C>C([O-])(=O)C.[Pd+2].C([O-])(=O)C.O.CC(C)=O>[Cl:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[N:7]([CH2:11][C:12]([O:14][CH2:44][CH3:45])=[O:13])[CH:6]([CH3:15])[C:5]2=[C:16]1[CH:17]=[CH:18][C:19]2[C:20]([CH:28]=[CH:27][N:26]=2)=[CH:25]1참가 물질
8
반응물 4
생성물 1
시약·촉매·용매 3
실험 절차
The product of Example 51 part b (200 mg), 5-indole boronic acid (100 mg), potassium carbonate (0.73 g), acetone (6 ml), water (3 ml), palladium acetate (12 mg) and tri(o-tolyl) phosphine (30 mg) were heated at 90° C. for 4 hours. The reaction mixture was concentrated in vacuo, purified by silica chromatography eluting with hexane:EtOAc (7:3) to give the sub-title compound (140 mg).
후처리
- concentrationThe reaction mixture was concentrated in vacuo
- custompurified by silica chromatography
- washeluting with hexane:EtOAc (7:3)
출처 및 근거
- ORD 기록
- ord-30f7720dcc3e4848865d428ed4cda11c
- 출처 데이터셋
- uspto-grants-2012_01
- 특허 번호
- US08093278B2
연결된 노트
불러오는 중…